India’s CLEAR Breakthrough Could Transform Protein Imaging for Cancer and Neurological Research
Traditional immunofluorescence imaging has been one of the most useful tools for studying proteins in their natural cellular environment. Its limitation, however, has been multiplexing capacity. Conventional methods are usually restricted to around four or five protein targets because different fluorescent dyes overlap spectrally and become difficult to separate cleanly. The CLEAR platform tackles this bottleneck by allowing the same sample to be labelled, imaged, erased and labelled again in repeated cycles.